2026-07-21

Great News | Imported API Furosemide Receives NMPA Marketing Approval

Our company's imported active pharmaceutical ingredient (API) Furosemide has officially received...

2026-07-10

NMPA-Approved Vonoprazan Fumarate Tablets – Seeking Global Partners

We are pleased to announce that Lunarsun Pharma's Vonoprazan Fumarate Tablets have obtained NMPA...

2026-07-02

Congratulations to Chongqing Saintsun Pharmaceutical Co., Ltd. on Obtaining the Drug Registration Certificate for its developed product, Sodium Thiosulfate Injection

Chongqing Saintsun Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Lunarsun Pharmaceutical, h...